FOLFOXIRI plus cetuximab as conversion therapy for unresectable RAS/BRAF wild-type left-sided colorectal cancer with liver-limited metastases: a prospective dual-center pilot study
Article in Frontiers in Oncology (April 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (April 2024)
Article in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (January 2022)